HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A complex composed of USF1 and USF2 activates the human FcepsilonRI alpha chain expression via a CAGCTG element in the first intron.

Abstract
The high-affinity IgE receptor, FcepsilonRI, is a key regulatory molecule in the allergic reaction. During the course of studies to find cis-acting elements for FcepsilonRI alpha chain gene expression, a CAGCTG sequence located in the first intron was revealed to serve as a crucial enhancer element. Electromobility shift assays using antibodies and in vitro translation products showed that the CAGCTG element was recognized by the USF1/USF2 complex. As was the case for other intronic cis-elements, the CAGCTG element regulated the promoter in an orientation- and position-dependent manner. Overexpression of USF2 antisense repressed the FcepsilonRI alpha chain gene promoter and decreased the amount of alpha chain mRNA in mast cell lines. All these results indicated that the USF1/USF2 complex activates the human FcepsilonRI alpha chain gene expression via the CAGCTG element in the first intron.
AuthorsK Takahashi, C Nishiyama, M Nishiyama, K Okumura, C Ra, Y Ohtake, T Yokota
JournalEuropean journal of immunology (Eur J Immunol) Vol. 31 Issue 2 Pg. 590-9 (Feb 2001) ISSN: 0014-2980 [Print] Germany
PMID11180124 (Publication Type: Journal Article)
Chemical References
  • Antisense Elements (Genetics)
  • DNA-Binding Proteins
  • Receptors, IgE
  • Transcription Factors
  • USF1 protein, human
  • USF2 protein, human
  • Upstream Stimulatory Factors
  • Usf1 protein, rat
  • Usf2 protein, rat
Topics
  • Animals
  • Antisense Elements (Genetics) (pharmacology)
  • Cells, Cultured
  • DNA-Binding Proteins
  • Dimerization
  • Enhancer Elements, Genetic
  • Gene Expression Regulation
  • Humans
  • Introns
  • Rats
  • Receptors, IgE (genetics)
  • Transcription Factors (chemistry, physiology)
  • Transfection
  • Upstream Stimulatory Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: